Table 1

Participant characteristics by study group

Group A: ACT subsidy
RDT subsidy
N=116
Group B: RDT subsidy
N=107
Group C: ACT subsidy
N=114
Group D: no subsidy (reference) N=107Total
N=444
Female71 (61%)63 (59%)76 (67%)69 (64%)279 (63%)
Patient age (years)
 0 to 538 (33%)28 (26%)35 (31%)23 (21%)124 (28%)
 >5 to <1841 (35%)32 (30%)32 (28%)45 (42%)150 (34%)
 18 to <3522 (19%)23 (21%)21 (18%)15 (14%)81 (18%)
 35+15 (13%)24 (22%)26 (23%)24 (22%)89 (20%)
Household size
 Median (IQR)6 (5–7)6 (4–8)6 (5–7)6 (5–8)6 (4–7)
Highest level of education completed
 <Primary or none3 (3%)2 (2%)5 (4%)3 (3%)13 (3%)
 Primary69 (59%)67 (63%)71 (62%)72 (67%)279 (63%)
 Secondary44 (38%)38 (36%)38 (33%)32 (30%)152 (34%)
Occupation
 Farming73 (63%)64 (60%)69 (61%)69 (64%)275 (62%)
 Unemployed11 (9%)13 (12%)16 (14%)13 (12%)53 (12%)
 Employed13 (11%)10 (9%)8 (7%)9 (8%)40 (9%)
 Self-employed/other19 (16%)20 (19%)21 (18%)16 (15%)76 (17%)
Wealth category
 Poorest 40th centile45 (40%)36 (36%)45 (40%)46 (44%)172 (40%)
Distance to facility (km)
 Median (IQR)2.1 (1.5–2.8)2.2 (1.6–2.7)2.2 (1.5–2.9)2.0 (1.4–2.8)2.2 (1.5–2.8)
Distance to enrolled shop (km)
 Median (IQR)1.4 (1.0–2.1)1.6 (0.9–2.2)1.6 (1.0–2.1)1.7 (1.0–2.1)1.6 (1.0–2.2)
 Has 1 week follow-up116 (100%)103 (96%)114 (100%)104 (97%)437 (98%)
  • ACT, artemisinin combination therapy; RDT, rapid diagnostic test.